88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Ractigen Therapeutics Announces U.S. FDA IND Clearance for First-in-Class saRNA Candidate RAG-1C to Treat Proliferative Vitreoretinopathy RAG-1C achieves dual IND clearances from both U.S. FDA and China CDE, paving the way for global clinical development of the world's first saRNA therapy for ocular diseases RAG-1C utilizes Ractigen's ... 2026-07-31T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia for Senaparib in Europe, Middle East and North Africa, Australia and New Zealand SHANGHAI , July 31, 2026 /PRNewswire/ -- IMPACT Therapeutics ("IMPACT") (07630.HK) is pleased to announce that it has entered into an exclusive partnership (the "Exclusive Partnership") ... 2026-07-31T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
CellOrigin Unveils Two Novel Solid-Tumor Cell Therapy Candidates at ASCO 2026, Partners with Walvax for In Vivo CAR Clinical Trial HANGZHOU, China , July 31, 2026 /PRNewswire/ -- CellOrigin, a biotechnology company focused on next-generation in vivo and in vitro cell therapy technologies, has announced two major progresses in ... 2026-07-31T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Telix H1 2026 Results: Investor Webcast Notification MELBOURNE, Australia and INDIANAPOLIS, July 31, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that it will release its financial results ... 2026-07-31T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
HKEY-AI2Vivo™ 1.0: HKeyBio Accelerates In Vivo Translation for AI-Designed Candidates HKEY-AI2Vivo™ 1.0 supports the move from computational hypotheses to in vivo translational evidence in autoimmune and allergy research ... 2026-07-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Medicine Launches the Industry's First Drug Discovery and Development (DDD) Benchmark as a Service, to Evaluate Frontier AI and Foundation Models on Real-World Science Leveraging 30+ validated PCC programs and over 12 years of model development experience to create a large-scale real-world "blind test" for frontier AI and foundation models, with a transparent ... 2026-07-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Continuity Biosciences Appoints Vicky Papoutsis to Board of Directors Business development and corporate strategy executive joins Board as Company advances its clinical programs and partnering activity ... 2026-07-30T Biotechnology Health Care/Hospital
NMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC CHENGDU, China , July 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application ... 2026-07-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Propel Health Australia Highlights Emerging Research into Fulvic Acid and Microplastics BRISBANE, Australia , July 30, 2026 /PRNewswire/ -- Propel Health is highlighting new laboratory research published in Science of the Total Environment showing that fulvic acid can interact ... 2026-07-30T Biotechnology Health Care/Hospital
Piramal Pharma Limited Announces Results for Q1 FY27 MUMBAI, India , July 30, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated ... 2026-07-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved